Cloud-based computing could offer major benefits to pharmaceutical companies in the area of drug development as they grapple with rising costs and avalanches of data that need to be collected, analyzed and shared.
In particular, the technology could help streamline operations and develop business cases as to whether a drug is likely to be needed — or financially viable.
“If you’ve got big pots of...
Pharmaceutical company UCB and DEARhealth, a disease management software company, are joining forces on a new initiative aimed at predicting health outcomes for patients with epilepsy. The pair will use DEARhealth’s platform, which integrates artificial intelligence with EHRs.
“This technology will ensure that specific subpopulations within epilepsy will all receive the specific care needed for...
Cloud technology opens up the potential for exciting innovations when it comes to the design and execution of clinical trials, but data security and privacy concerns are holding innovation at a snail’s pace.
Despite these misgivings, cloud-based solutions could in fact offer greater security, as well as the ability to access large pools of data that would improve an organization’s ability to...
Diving deeper into digital, this quarter the pharma giants have continued to implement new tools to enhance clinical trials, support medication management with technology and partner in developing digital therapeutics.
Onc, a foreign entity to this established industry, pharma executives are now becoming better versed in working with digital health companies and sharing the lessons they've...
It would be hard to discuss healthcare trends without talking about what this means for the behemoth pharma industry. Recently, new kid on the block digital health has started to turn heads in across this well-established sector with its potential for improving R&D, tracking real-world evidence and even creating a new type of medicine with digital therapeutics.
While digital promises the...
